Biomedtech News

October 21, 2019

ABIVAX Reports Impressive 12-month Efficacy and Safety Data from ABX464 Ulcerative Colitis Maintenance Study at United European Gastroenterology Conference

October 21, 2019

Impressive 12-month Efficacy and Safety Data from ABX464

September 12, 2019

FDA approval to launch a clinical feasibility study in the United States

August 19, 2019

Inclusion of the first patient in Abivax's Phase 2b (ABX464-103) clinical trial for the treatment of hemorrhagic rectocolitis

August 1, 2019

Abivax treats first rheumatoid arthritis patient in Phase 2a clinical trial

February 27, 2019

1st PET bottles from 100% biorecycled plastic waste

January 15, 2019

Positive interim results from the first part of the PIVOTAL study

Pages

1
2
3
4
5
6
7
8